Clinical Trials Logo

Respiratory Failure clinical trials

View clinical trials related to Respiratory Failure.

Filter by:

NCT ID: NCT00347321 Completed - Respiratory Failure Clinical Trials

Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)

ETOC
Start date: July 2006
Phase: Phase 3
Study type: Interventional

This is a phase III clinical trial comparing early tracheostomy (day 4) versus prolonged endotracheal intubation in ICU patients needing prolonged ventilatory support after cardiovascular surgery.

NCT ID: NCT00325611 Completed - Stroke Clinical Trials

Multidisciplinary Inpatient Palliative Care Intervention

Start date: April 2002
Phase: N/A
Study type: Interventional

Palliative care is believed to improve care of patients with life-limiting illnesses. This study evaluated the impact of a multi-center randomized trial of a palliative care team intervention on the quality and cost of care of hospitalized patients. Study subjects were randomized to intervention or usual care. At study end, patients receiving the palliative care intervention reported greater patient satisfaction with their care. Intervention patients also had significantly fewer ICU admissions and lower total costs for care 6 months past their hospitalization. Intervention patients completed more advance directives and had longer hospice stays.

NCT ID: NCT00315263 Completed - Respiratory Failure Clinical Trials

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

Start date: April 2006
Phase: N/A
Study type: Observational

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).

NCT ID: NCT00314080 Completed - Respiratory Failure Clinical Trials

Treatment of Survivors After Botulism Outbreak

Start date: March 2006
Phase: N/A
Study type: Observational

Background. Northern Thailand's biggest botulism outbreak to date occurred on 14 March 2006 and affected 209 people. Of these, 42 developed respiratory failure, and 25 of those who developed respiratory failure were referred to 9 high facility hospitals for treatment of severe respiratory failure and autonomic nervous system involvement. Among these patients, we aimed to assess the relationship between the rate of ventilator dependence and the occurrence of treatment by day 4 versus day 6 after exposure to bamboo shoots (the source of the botulism outbreak), as well as the relationship between ventilator dependence and negative inspiratory pressure. Methods. The investigators reviewed the circumstances and timing of symptoms following exposure. Mobile teams treated patients with botulinum antitoxin on day 4 or day 6 after exposure in Nan Hospital (Nan, Thailand). Eighteen patients (in 7 high facility hospitals) with severe respiratory failure received a low- and high-rate repetitive nerve stimulation test, and negative inspiratory pressure was measured.

NCT ID: NCT00297986 Completed - Healthy Clinical Trials

Evaluation of Different Interfaces for Noninvasive Positive Pressure Ventilation (NPPV)

Start date: June 2004
Phase: N/A
Study type: Observational

In this study the investigators aimed to study the ventilatory performance of different interfaces during NPPV delivering.

NCT ID: NCT00282594 Completed - Sepsis Clinical Trials

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Start date: July 2003
Phase: N/A
Study type: Interventional

We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.

NCT ID: NCT00248729 Completed - Respiratory Failure Clinical Trials

Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital.

Start date: October 2002
Phase: Phase 2
Study type: Interventional

The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance.

NCT ID: NCT00148642 Completed - Respiratory Failure Clinical Trials

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

NASCENT
Start date: November 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for >= 24 hours.

NCT ID: NCT00142766 Completed - Respiratory Failure Clinical Trials

Sedation Management in Pediatric Patients Supported on Mechanical Ventilation

Start date: February 2004
Phase: Phase 2
Study type: Interventional

The purpose of this two-year project is to pilot test an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the pediatric intensive care unit (PICU). While ensuring patient comfort is an integral part of pediatric critical care, analgesic and sedative use in this patient population is associated with injury; specifically, comfort medications may depress spontaneous ventilation and prolong the duration of mechanical ventilation. Additionally, drug tolerance develops over time and may precipitate iatrogenic abstinence syndrome (chemical withdrawal) when the patient no longer requires sedation. Alternatively, suboptimal comfort management contributes to the patient not breathing synchronously with the ventilator and/or self-removal of breathing tubes. Our group has developed and validated a nurse-implemented sedation algorithm (set of specific instructions) to guide titration of comfort medications that may optimize patient comfort and reduce the risk of under-medication, but this algorithm needs to be evaluated further. We hypothesize that pediatric patients managed per sedation protocol will experience fewer days of mechanical ventilation than patients receiving usual care. This research has the potential of revolutionizing sedation practices that are driven by and synchronized to patient needs.